Evercore ISI analyst Michael Newshel reiterated a Buy rating on Centene (NYSE:CNC) on Tuesday, setting a price target of $88, which is approximately 24.88% above the present share price of $70.47.
Newshel expects Centene to post earnings per share (EPS) of $1.20 for the third quarter of 2021.
The current consensus among 10 TipRanks analysts is for a Strong Buy rating of shares in Centene, with an average price target of $87.7.
The analysts price targets range from a high of $93 to a low of $75.
In its latest earnings report, released on 03/31/2021, the company reported a quarterly revenue of $29.98 billion and a net profit of $1.05 billion. The company's market cap is $41.07 billion.
According to TipRanks.com, Evercore ISI analyst Michael Newshel is currently ranked with 3 stars on a 0-5 stars ranking scale, with an average return of 5.8% and a 59.09% success rate.
Centene Corporation is a diversified healthcare company that primarily engages in providing programs and services to the government sponsored healthcare programs. The company is also engaged in providing education and outreach programs to assist members in accessing quality and appropriate healthcare services.